$MPLT insider trading

Over the last 12 months, MapLight Therapeutics insiders reported 2 buys totaling $15.5M and 7 sales totaling $11.5M across SEC Form 4 filings. 44% of the activity was filed under pre-arranged 10b5-1 trading plans.

$15.5M
$11.5M
9
8
44%
Side
$100K$1.0M$10M$100MJul '26Aug
Lillie James Woodruff
Catalyst4, Inc.
Cox Troy
Hanson Kristopher
Kreitzer Anatol

All insider trades

Aug 3, 2026Lillie James Woodruff▼ Sale22,082$12.54$277K-9.8%
Jul 30, 2026Catalyst4, Inc.▲ Buy1,209,225$12.66$15.3M+6.1%
Jul 28, 2026Cox Troy▲ Buy15,620$9.52$149K
Jul 17, 2026Foff Erin Pennock▼ Sale47,158$36.78$1.7M-13.6%
Jul 17, 2026Hanson Kristopher▼ Sale16,508$36.82$608K-10.2%
Jul 17, 2026GILLIS JONATHAN▼ Sale36,979$37.12$1.4M-20.4%
Jul 17, 2026Kreitzer Anatol▼ Sale36,284$37.09$1.3M-17.2%
Jul 17, 2026Kroeger Christopher A.▼ Sale147,639$36.87$5.4M-10.6%
Jul 17, 2026Lillie James Woodruff▼ Sale18,267$36.88$674K-7.5%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MPLT feed.

MPLT Insider Trading — Form 4 Buys & Sells | alphai